Pfizer says once-a-month weight-loss drug works as it for...
Pfizer on Tuesday hailed a study of a weight-loss-drug candidate while forecasting a profit decline because of the impact of the Trump ad...
What’s Happening
Not gonna lie, Pfizer on Tuesday hailed a study of a weight-loss-drug candidate while forecasting a profit decline because of the impact of the Trump administrations policies on pricing and tariffs.
More details are expected to emerge soon.
Why This Matters
Market watchers are paying close attention to developments like this.
This reflects broader trends we’re seeing in the business world right now.
The Bottom Line
This story is still developing, and we’ll keep you updated as more info drops.
Sound off in the comments.
Daily briefing
Get the next useful briefing
If this story was worth your time, the next one should be too. Get the daily briefing in one clean email.
Reader reaction
